Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation
An Update
AGID: Antibody Evaluation
April 2012
In that context, the autoimmune gastrointestinal dysmotility antibody evaluation can aid the diagnosis of both idiopathic autoimmune and paraneoplastic disorders and, as mentioned, multiple antibodies are commonly found coexisting together and the specific neoplasm may be predictable by the antibody profile. For example, ANNA-1 antibody with an N-type calcium channel antibody is predictive of small cell carcinoma.
AGID: Antibody Evaluation |
Jump to section:
- Introduction
- New Profile
- AGID
- Symptoms
- AGID1
- AGID1,2
- AGID: Laboratory Findings
- AGID: Antibody Evaluation
- Ganglionic Acetylcholine Receptor (AChR) Autoantibody3,4
- Ganglionic AChR Autoantibody
- AGID Antibody Profile
- AGIDE/89886 Algorithm
- AGIDE/89886 Algorithm
- AGIDE/89886 Algorithm
- AGIDE/89886 Algorithm
- Clinical Utility of AGID Evaluation
- Clinical Utility of AGID Evaluation
- Summary
- References
- Questions
External
link
PDF
document
Excel
document
Word
document